Clinical Trials Directory

Trials / Unknown

UnknownNCT02883725

National Register of Oesophageal Atresia

Status
Unknown
Phase
Study type
Observational
Enrollment
2,500 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers
Not accepted

Summary

The esophageal atresia is a group of birth defects including a break in continuity of the esophagus with or without persistent communication with the trachea (tracheoesophageal fistula), sometimes associated (from 50%) of other malformations (heart, kidney, digestive ...). The current prognosis for this ailment is good. However he persists a mortality (\<10%) and significant morbidity, firstly related malformations (heart, kidney, for example), and secondly with particularly difficult anatomical forms (Forms long defect) . The prevalence of this condition is estimated to be 1/2500 in 3000 live births, making an estimated ± 2,500 new cases over to 10 years in France. The current project aims to set up a national registry (Metropolitan France and Dom Tom) to measure the prevalence of esophageal atresia among live births, phenotypic characteristics, the circumstances of their diagnosis, and their initial future at short-term during the first year of life, at which time occurs the vast majority of deaths and complications in this disease.

Conditions

Interventions

TypeNameDescription
OTHERdata collection

Timeline

Start date
2008-01-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2016-08-30
Last updated
2022-05-18

Locations

37 sites across 3 countries: France, Guadeloupe, Martinique

Source: ClinicalTrials.gov record NCT02883725. Inclusion in this directory is not an endorsement.